Amyloidosis: Novel Treatments Could Improve Poor Outcomes

Apr 21, 2026

Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art Review

Read more

Apr 20, 2026

PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels (TRACE)

Read more

Apr 17, 2026

Neuropathy Assessment and Treatment Patterns in Patients With Hereditary Transthyretin Amyloidosis: A Single-Center Analysis of Stabilizer and Gene Silencer Utilization

Read more

Apr 16, 2026

Starting Attruby early cuts heart-related risks by half in ATTR-CM

Read more

Apr 16, 2026

TTR stabilizer therapy increases naturally occurring antibodies in ATTR-CM

Read more

Apr 15, 2026

Clinical Profiles, Treatment and Real-world Outcomes in Patients with ATTR-cardiac Amyloidosis: A Retrospective Study from Patients Referred for Scintigraphic Study

Read more

Apr 15, 2026

Disease burden of ATTR amyloidosis based on the SF-36® health survey

Read more

Apr 14, 2026

AL Amyloidosis Clinical Trials (April 2026)

Read more

Apr 14, 2026

Correlation between neuropathy severity and neurofilament light chain levels in Brazilian patients with hereditary transthyretin amyloidosis

Read more

Apr 13, 2026

Amvuttra effective in East Asian patients with hATTR-PN: Trial data

Read more

Subscribe to